-
Therapy Trial for PPF and IPF Patients
I just read about this trial today and thought I’d share the information here.
pharmacytimes.com
FDA Grants Breakthrough Therapy Designation to Novel Drug for Progressive Pulmonary Fibrosis
BMS-986278 (Bristol Myers Squibb) is a potential first-in-class treatment for progressive pulmonary fibrosis and idiopathic pulmonary fibrosis.
Sorry, there were no replies found.
Log in to reply.